Integer Holdings Corporation

Integer Holdings Corporation

Integer Holdings Corporation

Overview
Date Founded

1997

Headquarters

2595 Dallas Parkway,Suite 310,Frisco, TX 75034

Type of Company

Public

Employees (Worldwide)

8,250

Industries

Medical Products & Equipment
Medical Support Services
Industrial Machinery & Manufacturing
Hospitals & Patient Services
Electrical Products

Company Description

Integer Holdings Corp. engages in manufacturing and developing of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment include cardio and vascular; cardiac and neuromodulation; and advanced surgical, orthopedics, and portable medical. The Non-Medical segment provides battery packs to the energy, military, and environmental markets for use in extreme environments, with the Electrochem as its product. The firm's products include batteries, capacitors, catheters, and guidewires. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.

Contact Data
Trying to get in touch with decision makers at Integer Holdings Corporation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Chief Financial Officer & Executive Vice President

Chief Information Officer

Executive Vice President & Chief Human Resources Officer

Vice President, Corporate Controller & Principal Accounting Officer

Chief Executive Officer & Founding Partner, QIG Group

President, Cardio & Vascular

Executive Vice President-Quality & Regulatory Affairs

Senior Vice President-Global Operations

Vice President, Integration & Operations Planning

Board of Directors

Founder at Symark LLC

Operating Executive at The Carlyle Group LP (Corporate Private Equity)

Chief Technology & Innovation Officer at Parker-Hannifin Corporation

Director, President & Chief Executive Officer at Integer Holdings Corporation

Founding Partner at Glengary LLC

Former Global Strategy Partner at PricewaterhouseCoopers LLP

Chief Financial Officer at Cibus Ltd.

Executive Director at Albertson's LLC

Founder at Worthy Ventures Resources, LLC

Former President-Sleep & Home Respiratory Group at Respironics, Inc.

Paths to Integer Holdings Corporation
Potential Connections via
Relationship Science
You
Integer Holdings Corporation
Owners & Shareholders
Details Hidden

Silvercrest Asset Management Group is an independent, employee-owned, registered investment advisor which provides asset management and family office services to families and select institutional investors. Silvercrest combines the client-focused service which was the hallmark of private banks and investment counsel firms in an earlier age with state of the art theories of portfolio construction, risk management and diversification. Silvercrest's professionals have dedicated their careers to wealth management and our Managing Directors, who average more than 25 years of wealth management experience, have advised their clients through the boom of bull markets and the gloom of bear markets. We are not swayed by market manias. We are only interested in seeing our clients' assets invested in a manner consistent with their tolerance for risk. Silvercrest currently advises on $11.2 billion* for a clientele comprised primarily of families, as well as endowments, foundations and other institutional investors. Silvercrest's family office, advisory and investment capabilities are available to clients interested in investing substantial assets. Silvercrest is free from the numerous conflicts of interest inherent to larger organizations. Our size, our employee ownership and our collegial culture-coupled with the spirit, camaraderie and character of our organization-stand in sharp contrast to much of Wall Street and the financial services industry. We enjoy working with one another and we enjoy working with our clients. The quality, integrity and independence of our advice, coupled with our unwavering commitment to client service, sets us apart in a crowded field.

Details Hidden

Clark Capital Management Group is a family and employee owned Independent Investment Advisory firm providing institutional-quality investment solutions to individual investors, corporations, foundations, and retirement plans. Founded in 1986 we are one of the oldest and most experienced firms currently offering our solutions to the independent Wealth Advisors. With over 20 years experience providing wealth management solutions to individual investors, Clark Capital has navigated our clients' wealth through a variety of investment environments. There is no substitute for experience, and our seasoned team of portfolio managers has allowed Clark Capital to successfully deliver on our investment management promise. Our investment staff is comprised of nine professionals with a combined one hundred seventy years of experience and includes three Chartered Financial Analysts (CFA). We offer sophisticated investment solutions to Wealth Advisors and their clients, solutions that are designed to be easy to implement and access. Our hallmark is Innovation, which we believe is a necessity in the ever changing investment climate of today and tomorrow. Sophistication and Innovation are always tempered by our commitment to effective risk management and grounded in the realization that we must be Flexible and Responsive to clients' needs and to the ever changing climate of the world wide investment scene

Details Hidden

Channing Capital Management employs a long-term value-oriented approach to investing in US mid-cap and small-cap stocks. The firm utilizes a fundamental, bottom-up value investment philosophy that focuses on undervalued and neglected stocks primarily with a market-cap of $2 billion to $15 billion. They look for companies that are trading at significant discounts to their intrinsic value. Portfolios are constructed on a stock-by-stock basis with a focus on the return potential of individual securities. Channing's relatively concentrated approach focuses on stock picking rather than market timing or sector allocation. The firm relies primarily on stock selection to generate above average returns as opposed to forecasts which emphasize sector weightings relative to a portfolio benchmark. However, Channing does employ sector and industry diversification as a risk management tool.

Recent Transactions
Details Hidden

Viant Medical LLC purchases Integer Holdings Corp. /AS&O Business from Integer Holdings Corporation

Details Hidden

purchases Nuvectra Corp. from Integer Holdings Corporation

Details Hidden

Integer Holdings Corporation purchases Lake Region Manufacturing, Inc. from Bain Capital Private Equity LP, Lake Region Medical, Inc., Kohlberg Kravis Roberts & Co. LP

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onInteger Holdings Corporation purchases Lake Region Manufacturing, Inc. from Bain Capital Private Equity LP, Lake Region Medical, Inc., Kohlberg Kravis Roberts & Co. LP

Underwriter

Advised onInteger Holdings Corporation issued USD Common Stock

Underwriter

Advised onInteger Holdings Corporation issued USD Common Stock

Legal Advisor

Advised onInteger Holdings Corporation purchases Precimed SA from HBM Partners AG, Ypsomed Holding AG, Vinci Capital Switzerland SA, BV Holding AG

Attorney

Advised onViant Medical LLC purchases Integer Holdings Corp. /AS&O Business from Integer Holdings Corporation

Attorney

Advised onViant Medical LLC purchases Integer Holdings Corp. /AS&O Business from Integer Holdings Corporation

Advisors & Consultants
Advisor

Chief Human Resources Officer at Albireo Pharma, Inc.

Legal Advisor

Partner at Arnall Golden Gregory LLP

Advisor

Strategic Advisor, Technology & Business Development at AdvaStim, Inc.

Clients

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Key Stats and Financials As of 2019
Market Capitalization
$1.9B
Total Enterprise Value
$3.5B
Earnings Per Share
$2.77
Revenue
$1.26B
Total Equity
$1.15B
Total Debt
$859M
Net Profit
$91.4M
EBITDAMargin
21.31%
EBITDA
$268M
Enterprise Value Sales
2.78x
TEVNet Income
38.34x
Enterprise Value EBITDAOperating
12.88x
Debt TEV
0.25x
Three Year Compounded Annual Growth Rate Of Revenue
-3.16%
Five Year Compounded Annual Growth Rate Of Revenue
12.86%
Non-Profit Donations & Grants
Investments
Details Hidden

Cardionomic, Inc. develops medical devices. It offers non-systemic therapy for acute decompensated heart failure that uses neuromodulation to improve cardiac output, renal blood flow, urine production and pharmacological tolerance. The company was founded in 2011 and is headquartered in New Brighton, MN.

Details Hidden

Intelect Medical, Inc. provides health care services. The firm develops therapies for the recovery of chronic strokes and traumatic brain injuries. It offers deep brain stimulation and implantable neuro modulation systems for brain injury recovery. The company was founded in April 2005 and is headquartered in Marlborough, MA.

Details Hidden

Imalux, the medical device company on a mission. They're leading the world in the development of Optical Coherence Tomography (OCT), a breakthrough medical imaging modality used to visualize tissue microstructure in real-time, at the site of patient care. With the Niris Imaging System, its first generation OCT solution, Imalux provides physicians and surgeons a valuable tissue-profiling tool to assist in the diagnosis, treatment, and surveillance of disease.Currently, clinicians do not have effective imaging methods for detecting tissue structure abnormalities in a timely manner and at the point-of-care. Physicians, therefore, must rely on prior imaging studies and visual findings to guide surgery and treatment. There exists an unmet need for real-time, high spatial resolution medical imaging that can be used in a wide range of applications and practice settings at a reasonable cost. Globally, the healthcare community is searching for ways to streamline the delivery of care without compromising clinical outcomes. The Imalux Niris Imaging System offers clinicians the ability to 'see and treat' in a single patient visit a single episode of care. Imalux is developing products and services to address this serious clinical need that cannot be satisfied by current technologies.In time, Imalux anticipates that Optical Coherence Tomography will take its place alongside x-ray, ultrasound, Magnetic Resonance Imaging (MRI), Computerized Axial Tomography (CT scans), and nuclear medicine as the 'sixth imaging modality.' At present, research efforts continue as Imalux conducts further studies to establish the value of OCT in clinical settings and lead to eventual commercialization of the technology.

Investors
Details Hidden

aPriori Capital Partners focuses on mid-market opportunities in the US and Europe whose enterprise value from USD100 million to USD 5billion. The firm target companies operating in the fields of retail and consumer, business Services, healthcare, energy and Industrial services. They also takes majority and control position.

Details Hidden

Director & Senior Wealth Manager at Carnegie Capital Asset Management LLC

Suppliers
Nuvectra Corp. Medical Support Services | Plano, TX

Nuvectra Corp. is a neurostimulation medical device company, which engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra segment. The Nuvectra segment is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The company was founded on November 14, 2008 and is headquartered in Plano, TX.

Akers Biosciences, Inc. Biotechnology | West Deptford, NJ

Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Integer Holdings Corporation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Integer Holdings Corporation's profile does not indicate a business or promotional relationship of any kind between RelSci and Integer Holdings Corporation.